Sanofi Suffers Second Clinical Setback For Venglustat

Fails In Rare Genetic Kidney Disease Trial

 
• By Kevin Grogan
  
Sanofi Lyon
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip